Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1977 3
1978 2
1979 2
1980 2
1981 3
1982 3
1983 4
1984 4
1985 8
1986 4
1987 1
1988 6
1989 3
1990 1
1991 3
1992 6
1993 8
1994 5
1995 11
1996 4
1997 7
1998 9
1999 10
2000 13
2001 14
2002 5
2003 12
2004 18
2005 18
2006 13
2007 11
2008 31
2009 21
2010 29
2011 25
2012 20
2013 27
2014 22
2015 6
2016 11
2017 14
2018 10
2019 19
2020 20
2021 17
2022 17
2023 18
2024 11
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

489 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: papadimitriou c. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Saving Shared Decision-Making.
Opel DJ, Gerstein MT, Carle AC, Fournier AK, Hargraves I, Lafata JE, Lipstein EA, Mallinson T, Moise N, Neuman HB, Nix M, Papadimitriou C, Scherer L, Sepucha K, Simpson M, Schwartz A, Stevens-Lapsley JE, Dickert NW. Opel DJ, et al. Among authors: papadimitriou c. J Gen Intern Med. 2025 Feb 14. doi: 10.1007/s11606-025-09410-z. Online ahead of print. J Gen Intern Med. 2025. PMID: 39953310
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer.
Van Gorp T, Cibula D, Lv W, Backes F, Ortaç F, Hasegawa K, Lindemann K, Savarese A, Laenen A, Kim YM, Bodnar L, Barretina-Ginesta MP, Gilbert L, Pothuri B, Chen X, Flores MB, Levy T, Colombo N, Papadimitriou C, Buchanan T, Hanker LC, Eminowicz G, Rob L, Black D, Lichfield J, Lin G, Orlowski R, Keefe S, Lortholary A, Slomovitz B; ENGOT-en11/GOG-3053/KEYNOTE-B21 investigators. Van Gorp T, et al. Among authors: papadimitriou c. Ann Oncol. 2024 Nov;35(11):968-980. doi: 10.1016/j.annonc.2024.08.2242. Epub 2024 Sep 14. Ann Oncol. 2024. PMID: 39284383 Free article. Clinical Trial.
Neuroscience Needs Network Science.
Barabási DL, Bianconi G, Bullmore E, Burgess M, Chung S, Eliassi-Rad T, George D, Kovács IA, Makse H, Nichols TE, Papadimitriou C, Sporns O, Stachenfeld K, Toroczkai Z, Towlson EK, Zador AM, Zeng H, Barabási AL, Bernard A, Buzsáki G. Barabási DL, et al. Among authors: papadimitriou c. J Neurosci. 2023 Aug 23;43(34):5989-5995. doi: 10.1523/JNEUROSCI.1014-23.2023. J Neurosci. 2023. PMID: 37612141 Free PMC article.
Editorial: Community reintegration after spinal cord injury.
Musselman KE, Papadimitriou C, Vasilchenko E. Musselman KE, et al. Among authors: papadimitriou c. Front Rehabil Sci. 2022 Sep 20;3:1020279. doi: 10.3389/fresc.2022.1020279. eCollection 2022. Front Rehabil Sci. 2022. PMID: 36204601 Free PMC article. No abstract available.
Neuroscience needs Network Science.
Barabási DL, Bianconi G, Bullmore E, Burgess M, Chung S, Eliassi-Rad T, George D, Kovács IA, Makse H, Papadimitriou C, Nichols TE, Sporns O, Stachenfeld K, Toroczkai Z, Towlson EK, Zador AM, Zeng H, Barabási AL, Bernard A, Buzsáki G. Barabási DL, et al. Among authors: papadimitriou c. ArXiv [Preprint]. 2023 May 11:arXiv:2305.06160v2. ArXiv. 2023. Update in: J Neurosci. 2023 Aug 23;43(34):5989-5995. doi: 10.1523/JNEUROSCI.1014-23.2023. PMID: 37214134 Free PMC article. Updated. Preprint.
Prophylactic mastectomy: an appraisal.
Zagouri F, Chrysikos DT, Sergentanis TN, Giannakopoulou G, Zografos CG, Papadimitriou CA, Zografos GC. Zagouri F, et al. Among authors: papadimitriou ca. Am Surg. 2013 Feb;79(2):205-12. Am Surg. 2013. PMID: 23336662 Review.
Inflammation markers in essential hypertension.
Tsounis D, Bouras G, Giannopoulos G, Papadimitriou C, Alexopoulos D, Deftereos S. Tsounis D, et al. Among authors: papadimitriou c. Med Chem. 2014;10(7):672-81. doi: 10.2174/1573406410666140318111328. Med Chem. 2014. PMID: 25102200 Review.
The Role of EMT-Related lncRNAs in Ovarian Cancer.
Lampropoulou DI, Papadimitriou M, Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G, Gazouli M. Lampropoulou DI, et al. Among authors: papadimitriou c. Int J Mol Sci. 2023 Jun 13;24(12):10079. doi: 10.3390/ijms241210079. Int J Mol Sci. 2023. PMID: 37373222 Free PMC article. Review.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Vergote I, Perez Fidalgo A, Valabrega G, Monk BJ, Herzog T, Cibula D, Colombo N, Pothuri B, Sehouli J, Korach J, Barlin J, Papadimitriou CA, van Gorp T, Richardson D, McCarthy M, Antill Y, Mirza MR, Li K, Kalyanapu P, Slomovitz B, Coleman RL. Vergote I, et al. Among authors: papadimitriou ca. Int J Gynecol Cancer. 2024 Aug 5;34(8):1283-1289. doi: 10.1136/ijgc-2024-005412. Int J Gynecol Cancer. 2024. PMID: 38627035 Free PMC article.
489 results